Danda Trouve Investment Management, Inc. Natera, Inc. Call Options Transaction History
Danda Trouve Investment Management, Inc.
- $54.1 Million
- Q3 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NTRA
# of Institutions
724Shares Held
125MCall Options Held
590KPut Options Held
246K-
Vanguard Group Inc Valley Forge, PA12.7MShares$2.52 Billion0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$2.42 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.46 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.35 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.82MShares$959 Million3.66% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $19.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...